| Advertisement Name : |
Online applications are invited for the post of “Research Project Manager” under MK3475-593:
A Prospective, Open-label, Phase 4 Study to Evaluate the safety of Pembrolizumab (KEYTRUDA
®) in subject with Unsearchable or metastatic Melanoma or PD-L1 positive Non-small Cell Lung
Cancer (NSCLC) in India (Keynote-593)”, Project (A/c no. 4386). (Initially for a period of six
months).
|